Kasai T - Search Results

1

Effects of patent ductus arteriosus on left ventricular output and organ blood flows in preterm infants with respiratory distress syndrome treated with surfactant.

Shimada S, Kasai T, Konishi M, Fujiwara T. Shimada S, et al. Among authors: kasai t. J Pediatr. 1994 Aug;125(2):270-7. doi: 10.1016/s0022-3476(94)70210-1. J Pediatr. 1994. PMID: 8040777

2

Carotid arterial impedance during oscillated blood flow.

Kobayashi S, Nitta S, Yambe T, Naganuma S, Tanaka M, Kasai T, Hashimoto H. Kobayashi S, et al. Among authors: kasai t. Artif Organs. 1994 Sep;18(9):627-32. doi: 10.1111/j.1525-1594.1994.tb03390.x. Artif Organs. 1994. PMID: 7998877

3

Treatment of endotoxemia with low-dose intramuscular injections or oral administration of polymyxin B.

Endo S, Inada K, Inoue Y, Fujii N, Yamada Y, Takakuwa T, Kasai T, Terashima M, Hoshi S, Yoshida M. Endo S, et al. Among authors: kasai t. Clin Ther. 1992 Jan-Feb;14(1):64-7. Clin Ther. 1992. PMID: 1576627 Clinical Trial.

4

The effects of immune globulin on endotoxemia.

Endo S, Inada K, Yamada Y, Takakuwa T, Nakae H, Kasai T, Kikuchi M, Terashima M, Hoshi S, Yoshida M. Endo S, et al. Among authors: kasai t. Clin Ther. 1992 Nov-Dec;14(6):781-4. Clin Ther. 1992. PMID: 1286485

5

Surfactant replacement therapy in premature babies with respiratory distress syndrome: factors affecting the response to surfactant and comparison of outcome from 1982-86 and 1987-91.

Konishi M, Chida S, Shimada S, Kasai T, Murakami Y, Cho K, Fujii Y, Maeta H, Fujiwara T. Konishi M, et al. Among authors: kasai t. Acta Paediatr Jpn. 1992 Dec;34(6):617-30. doi: 10.1111/j.1442-200x.1992.tb01021.x. Acta Paediatr Jpn. 1992. PMID: 1285509

6

A prospective, randomized trial of early versus late administration of a single dose of surfactant-TA.

Konishi M, Fujiwara T, Chida S, Maeta H, Shimada S, Kasai T, Fujii Y, Murakami Y. Konishi M, et al. Among authors: kasai t. Early Hum Dev. 1992 Jun-Jul;29(1-3):275-82. doi: 10.1016/0378-3782(92)90164-c. Early Hum Dev. 1992. PMID: 1396252 Clinical Trial.

7

Levels of soluble adhesion molecules and cytokines in patients with septic multiple organ failure.

Endo S, Inada K, Kasai T, Takakuwa T, Yamada Y, Koike S, Wakabayashi G, Niimi M, Taniguchi S, Yoshida M. Endo S, et al. Among authors: kasai t. J Inflamm. 1995-1996;46(4):212-9. J Inflamm. 1995. PMID: 8878795

8

Plasma levels of interleukin-1 receptor antagonist (IL-1ra) and severity of illness in patients with burns.

Endo S, Inada K, Yamada Y, Kasai T, Takakuwa T, Nakae H, Kamei Y, Shimamura T, Suzuki T, Taniguchi S, Yoshida M. Endo S, et al. Among authors: kasai t. J Med. 1996;27(1-2):57-71. J Med. 1996. PMID: 8863178

9

Nitrite/nitrate (NOx) and sFas antigen levels in patients with multiple organ failure.

Endo S, Inada K, Takakuwa T, Kasai T, Yamada Y, Wakabayashi G, Niimi M, Suzuki T, Taniguchi S. Endo S, et al. Among authors: kasai t. Res Commun Mol Pathol Pharmacol. 1996 May;92(2):253-6. Res Commun Mol Pathol Pharmacol. 1996. PMID: 8774078

10

Significance of alpha-tocopherol and interleukin 8 in septic adult respiratory distress syndrome.

Nakae H, Endo S, Inada K, Kasai T, Yoshida M. Nakae H, et al. Among authors: kasai t. Res Commun Chem Pathol Pharmacol. 1994 May;84(2):197-202. Res Commun Chem Pathol Pharmacol. 1994. PMID: 8091005

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results